600351.SS
600351.SS
CNE000001CM5
YABAO PHARMACEUTICAL GROUP CO L
Loading chart...

Company Profile

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

Related stocks

600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%
002393.SZ
002393.SZ • China
LISHENGPHARMA
14.25 CNY
657.37M USD 1Y -26.5%
000078.SZ
000078.SZ • China
NEPTUNUS
1.46 CNY
574.81M USD 1Y -41.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
36.8% p.a.
Max Drawdown (5Y)
-54.3%
Sharpe Ratio (5Y)
-0.07
Beta Factor
0.04
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.0% in the extended horizon.
ende